Last updated 2026-06-18
- Raised $19.7M funding round led by Pontifax, May 2019
- Raised funding round, Jan 2017
Total raised
$19.7M
Last: 2019-05
Stage
Series B
Founded
2015
Headcount
6
HQ
Netanya, Israel
Sector
Health Tech & Life Sciences
About
Pi Therapeutics is a preclinical-stage pharmaceutical company dedicated to the development of protein degradation modulators for the treatment of cancer. The companys lead drug modulates pathways related to proteostasis, offering a unique approach to the preferential targeting of cancer cells. Preclinical data to date have demonstrated a compelling safety and efficacy profile which is differentiated from approved protein degradation inhibitors. The company targets hematologic as well as solid tumor indications and expects to initiate clinical studies next year. Pi Therapeutics was founded based on technology in-licensed from Johns Hopkins University.
Funding history · 2 rounds · $19.7M total
Q&A
- What is the current status of Pi Therapeutics?
- Pi Therapeutics is currently inactive, having ceased operations in April 2023.
- What is Pi Therapeutics' primary focus?
- Pi Therapeutics is a preclinical-stage pharmaceutical company focused on developing protein degradation modulators for cancer treatment.
- When was Pi Therapeutics founded?
- Pi Therapeutics was founded in March 2015.
- What is the total amount of funding raised by Pi Therapeutics?
- Pi Therapeutics has raised a total of $19,700,000.
- When was Pi Therapeutics' last funding round and who were the lead investors?
- Pi Therapeutics' last funding round occurred in May 2019, with Pontifax as a lead investor.
- How many employees does Pi Therapeutics have?
- Pi Therapeutics has 1-10 employees.
- From where did Pi Therapeutics license its core technology?
- Pi Therapeutics was founded based on technology in-licensed from Johns Hopkins University.
- What types of cancer does Pi Therapeutics target with its lead drug?
- Pi Therapeutics targets hematologic as well as solid tumor indications with its lead drug.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
Verified
Tags
drug-discoverybiopharmaceuticalpharma-companiescancer
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2015-3 |
|---|---|
| Employees (exact) | 6 |
| Status reason | Non Active, Apr 2023 ceased to operate |